| Name | GSK4028 |
|---|---|
| Synonyms | 3(2H)-Pyridazinone, 4-bromo-2-methyl-5-[[(3S,5S)-1-methyl-5-phenyl-3-piperidinyl]amino] |
| Description | GSK4028 is the enantiomeric negative control of GSK4027, which is a PCAF/GCN5 bromodomain chemical probe, the pIC50 of GSK4028 is 4.9 in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. |
|---|---|
| Related Catalog | |
| Target |
pIC50: 4.9 (PCAF/GCN5)[1]. |
| In Vitro | GSK4028 is the enantiomeric negative control of GSK4027, which is a PCAF/GCN5 bromodomain chemical probe, the pIC50 of GSK4028 is 4.9. GSK4028 also demonstrates potency toward BRD4 BD1 and BRD9 inTR-FRET assay with pIC50s of <4.3 and 4.5±0.13, respectively[1]. |
| References |
| Molecular Formula | C17H21BrN4O |
|---|---|
| Molecular Weight | 377.28 |
| Storage condition | 2-8℃ |